<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thrombotic <z:hpo ids='HP_0001937'>microangiopathic hemolytic anemia</z:hpo> (TMHA) is not uncommon in clinical nephrology practice while <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) is uncommon </plain></SENT>
<SENT sid="1" pm="."><plain>Although less than 1% of patients with APS develop catastrophic APS (CAPS), its potential lethal outcome because of <z:mp ids='MP_0005048'>thrombosis</z:mp> in multiple organs and subsequent multiorgan failure emphasizes its importance in nephrology practice </plain></SENT>
<SENT sid="2" pm="."><plain>Here is a case of catastrophic APS in a 7-year-old girl, who presented to us with TMHA associated with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and subsequently died because of CAPS </plain></SENT>
</text></document>